Table 2.
Adverse events | n (%) |
---|---|
Infection | 4 (33.3) |
Upper respiratory tract infection | 3 (25.0) |
Viral keratitis | 1 (8.3) |
Dizziness | 2 (16.7) |
Edema | 2 (16.7) |
Chest pain, non-cardiac | 1 (8.3) |
Infusion reaction | 1 (8.3) |
Adverse events | n (%) |
---|---|
Infection | 4 (33.3) |
Upper respiratory tract infection | 3 (25.0) |
Viral keratitis | 1 (8.3) |
Dizziness | 2 (16.7) |
Edema | 2 (16.7) |
Chest pain, non-cardiac | 1 (8.3) |
Infusion reaction | 1 (8.3) |